Enlicitide achieved all primary and key secondary endpoints, demonstrating statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol
It offers clear environmental benefits, lower emissions, reduced hazardous material use, and alignment with circular economy goals
ITP is a disease of complex immune dysregulation leading to low platelet counts, bleeding, and reduced quality of life
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Treatment with Verzenio also resulted in sustained invasive disease-free survival and distant relapse-free survival benefit
As with any medicine, the MHRA will keep the safety of gepotidacin under close review
Triggering global regulatory submissions this year for the treatment of obesity
Merger is expected to streamline operations and provide unified management focus, driving efficiency and strategic alignment
The updated formula for Spikevax is now approved for individuals 6 months through 64 years of age
Subscribe To Our Newsletter & Stay Updated
